Aseptika Shortlisted for Three Upcoming Innovation Awards

HUNTINGDON, U.K. - Sept. 17, 2014 - PRLog -- 17 September, 2014, Aseptika Limited (Activ8rlives), Huntingdon, Cambridgeshire, UK:

Aseptika Ltd has been shortlisted for three business innovation awards in the coming month. The first is the Cambridge News Top Innovations (http://www.cambridge-news.co.uk/Innovations-2014/story-22802672-detail/story.html) awards, secondly the Discovery Start-up 2014 Competition (http://www.cambridgewireless.co.uk/Agenda/DS14%20-%20Agenda%20-%20Final%20V1.pdf) run by Cambridge Wireless and the third recently announced is the Hunts Post Huntingdonshire Business Innovation (http://www.huntsbusinessawards.co.uk/) Awards 2014. These nominations recognise Aseptika’s innovative respiratory hospital-at-home solution and biomarker test, which is currently running as the SENSOR (http://www.activ8rlives.com/sensor) clinical trial with a group of volunteer patients that suffer from COPD or severe Asthma in the Portsmouth area.

Dr. Kevin Auton, Managing Director of Aseptika Limited, commented:

“We are honoured to be short-listed for these awards and especially considering the high standard and innovation of the other UK SME companies also shortlisted.”

- Ends -

Caption: In an initiative lead by Aseptika, innovative healthcare trusts are developing partnerships with patients in which the patient, their family and healthcare team agree a self-management plan for use at home. Successful trials have shown 85% reduction in hospital admissions but the next step is to support the self-care plans by providing simple self-monitoring tools and a biomarker test for home use, that are web-connected.

About Aseptika Limited (Activ8rlives)

Aseptika Limited is a healthcare company developing and marketing an integrated suite of self-monitoring devices and services under the Activ8rlives brand. We are developing integrated systems which can be used by laypeople and their healthcare service providers to better self-manage (http://www.activ8rlives.com/solutions/self-monitoring-and...) long-term health conditions through self-monitoring.

The Company’s goal is to provide everyone with tools (and the understanding of how to apply them) so that most of us can keep healthy and well for most of the time. Self-management through self-monitoring is the motivation driving what we do.

Activ8rlives is unusual in that we are device agnostic, incorporating sensors and monitors ranging from consumer accessories to in vitro diagnostics (IVDs) with a focus on respiratory disease. All data is held together and can be cross analysed in the Cloud to provide forecasts and learning for the user and clinician.

The Company gained a patent in 2013 protecting the invention of a test for biomarkers (http://www.activ8rlives.com/about/news-and-events/news/20...) of Pseudomonas aeruginosa in the sputum of patients, which can be used to detect the on-set of an exacerbation and profile the efficacy of antibiotic treatment for each patient.

Aseptika won first place in a recent competition earlier in 2014 to reward the most “Promising eHealth EU SME”eHealth solution 2014 (http://www.activ8rlives.com/about/news-and-events/news/20...)developed by an early-stage European SME. The 2014 Competition was organized by TICBioMed and had the endorsement of the Health and Wellbeing Unit of DG CONNECT of the European Commission. The judges commended Aseptika for the integrated approach it was taking in the support of patients with long-term respiratory disease (http://www.activ8rlives.com/solutions/clinical-trials/), providing the platform to self-manage their illness through self-monitoring. Central to the Company’s “hospital-at-home” concept, is a test in which the patient measures the level of virulence of the bacteria living in their lungs which from time to time, flare into a full and repeated chest infections.

For more information on Aseptika Ltd and Activ8rlives and products, please visit: www.activ8rlives.com

Activ8rlives and Activ8rlives.com are trademarks of Aseptika Ltd.

For press information, please contact:

Jessica Auton, Marketing Director, Aseptika Ltd (Activ8rlives)

jessica.auton@aseptika.com

Direct +44 (0)1480 352 821

Mobile +44 (0)7455 922 122